Electrochemical Strategy for Eradicating Fluconazole-Tolerant Candida albicans Using Implantable Titanium.

Autor: Parry-Nweye E, Onukwugha NE, Balmuri SR, Shane JL, Kim D; Biofilm Research Laboratory, Department of Orthodontics and Divisions of Pediatric Dentistry & Community Oral Health, School of Dental Medicine , University of Pennsylvania , Philadelphia , Pennsylvania 19104 , United States., Koo H; Biofilm Research Laboratory, Department of Orthodontics and Divisions of Pediatric Dentistry & Community Oral Health, School of Dental Medicine , University of Pennsylvania , Philadelphia , Pennsylvania 19104 , United States., Niepa THR
Jazyk: angličtina
Zdroj: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2019 Nov 06; Vol. 11 (44), pp. 40997-41008. Date of Electronic Publication: 2019 Oct 28.
DOI: 10.1021/acsami.9b09977
Abstrakt: A persistent problem in modern health care derives from the overwhelming presence of antibiotic-resistant microbes on biomaterials, more specifically, fungal growth on metal-based implants. This study seeks to investigate the antifungal properties of low-level electrochemical treatments delivered using titanium electrodes against Candida albicans . We show that C. albicans can be readily controlled with electrical currents/potentials, reducing the number of viable planktonic cells by 99.7% and biofilm cells by 96.0-99.99%. Additionally, this study explores the ability of the electrochemical treatments to potentiate fluconazole, a clinically used antifungal drug. We have found that electrochemical treatment substantially enhances fluconazole killing activity. While fluconazole alone exhibits a low efficiency against the stationary phase and biofilm cells of C. albicans , complete eradication corresponding to 7-log killing is achieved when the antifungal drug is provided subsequently to the electrochemical treatment. Further mechanistic analyses have revealed that the sequential treatment shows a complex multimodal action, including the disruption of cell wall integrity and permeability, impaired metabolic functions, and enhanced susceptibility to fluconazole, while altering the biofilm structure. Altogether, we have developed and optimized a new therapeutic strategy to sensitize and facilitate the eradication of fluconazole-tolerant microbes from implantable materials. This work is expected to help advance the use of electrochemical approaches in the treatment of infections caused by C. albicans in both nosocomial and clinical cases.
Databáze: MEDLINE